Signos

Private

Palo Alto-based maker of the first FDA-cleared over-the-counter continuous glucose monitor (CGM) system for weight management. Powered by Dexcom's Stelo biosensor. Founded 2019.

Company

Founded
2019
Headquarters
Palo Alto, USA

Financials

Total Funding
$20M

Funding History

1 round

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.